For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
NERA’s global team of economic, statistical, and data experts works with many of the world’s leading pharmaceutical and biotechnology firms, regulators, tax authorities, and other entities to provide expert analysis and testimony across a number of disciplines.
Antitrust and Competition
In the past three years alone, NERA has represented clients in over 50 antitrust and competition matters involving pharmaceutical and biotechnology companies, including investigations before US and EU regulatory authorities, cases involving reverse payments, civil lawsuits alleging anticompetitive behavior, and pre-merger economic analysis and consulting. Our economists are well-versed in the unique competitive and regulatory issues faced by companies in the pharmaceutical and biotechnology industries and are deeply experienced in conducting the unbiased economic and statistical analysis and rigorous econometric modeling necessary to provide thoughtfully considered, highly defensible expert reports and testimony. Select examples of recent matters include:
Intellectual Property
Over the past three years, NERA’s intellectual property economists, survey experts, and social scientists have represented clients in more than 100 matters involving branded and generic pharmaceuticals, over-the-counter medications, and dietary supplements. Below are examples of recent matters:
Product Liability and Mass Torts
NERA experts have been analyzing personal injury and product liability issues for almost 15 years, assisting companies with projects related to product recalls, damages claims, insurance disputes, mergers and acquisitions and consumer class actions. Examples of recent matters include:
Securities
NERA is widely recognized as a leading provider of economic and financial analysis in securities and finance matters. Our experts work with pharmaceutical and biotechnology companies, directors and offices, regulators, and other entities in bet-the-company matters including mass torts, shareholder class actions, white collar criminal and regulatory enforcement actions, and commercial disputes. Examples of recent matters include:
Transfer Pricing
NERA’s global Transfer Pricing Practice provides clients in the pharmaceutical, biotechnology, cosmetics, and biologics industries with expert analysis, valuation support, and advice. Our experts frequently represent clients in matters before national and international tax authorities, serve as expert witnesses in litigation and arbitration, and provide guidance to regulatory bodies responsible for domestic and global tax policy. Examples of recent matters include:
Name | Title | Location | Phone | |
---|---|---|---|---|
Dr. Lawrence Wu | President | San Francisco | +1 415 291 1007 | lawrence.wu@nera.com |
Sarah Butler | Senior Managing Director | San Francisco | +1 415 291 1022 | sarah.butler@nera.com |
Dr. Yves Hervé | Senior Managing Director | Frankfurt | +49 69 710 447 508 | yves.herve@nera.com |
Bradley A. Heys | Senior Managing Director |
Toronto
New York City |
+1 416 868 7312
+1 212 345 3000 |
brad.heys@nera.com |
Dr. Vinita Juneja |
Senior Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice |
New York City
London Toronto |
+1 212 345 3148
+44 20 7659 8618 +1 416 868 7314 |
vinita.juneja@nera.com |
Dr. Christine Siegwarth Meyer |
Senior Managing Director
Chair of NERA's Intellectual Property Practice |
White Plains, NY | +1 914 448 4119 | christine.meyer@nera.com |
Dr. Lauren Stiroh | Senior Managing Director | White Plains, NY | +1 914 448 4143 | lauren.stiroh@nera.com |
Dr. David Blackburn | Managing Director | Washington, DC | +1 202 466 9264 | david.blackburn@nera.com |
Kristopher Boushie | Managing Director | Washington, DC | +1 202 466 9228 | kristopher.boushie@nera.com |
Mary Elizabeth C. Stern | Managing Director | White Plains, NY | +1 914 448 4054 | mary.elizabeth.stern@nera.com |
Dr. Chris Stomberg | Managing Director | Washington, DC | +1 202 466 9219 | chris.stomberg@nera.com |
Dr. Paul Wong | Managing Director | San Francisco | +1 415 291 1030 | paul.wong@nera.com |
Dr. Alan Grant | Director | Washington, DC | +1 202 466 3510 | alan.grant@nera.com |
Dr. Melissa Pittaoulis | Director | Philadelphia | +1 215 864 3879 | melissa.pittaoulis@nera.com |
Healey Whitsett | Director | Washington, DC | +1 202 466 9202 | healey.whitsett@nera.com |
Dr. Claire Chunying Xie | Director | Washington, DC | +1 202 466 3510 | claire.xie@nera.com |
Alexis Jin | Consultant | Chicago | +1 312 573 4804 | alexis.jin@nera.com |
Dr. Alan Cox | Affiliated Consultant | San Francisco | +1 415 291 1000 | alan.cox.affiliate@nera.com |
Dr. Thomas McCarthy | Affiliated Consultant | Los Angeles | +1 213 346 3000 | thomas.mccarthy.affiliate@nera.com |
Title | Date | |||
---|---|---|---|---|
GCR Live: Antitrust in Pharmaceuticals | 01 December 2022 | |||
8th Annual World Life Sciences Conference | 04 June 2022 | |||
Pharmaceutical Antitrust Updates: Latest Court Decisions, Congressional Bills, and Pr... | 17 February 2022 | |||
L’application Du Droit de la Concurrence au Secteur Pharmaceutique | 27 January 2022 | |||
Developments in Pharma Antitrust: Evolution or Revolution? | 24 January 2022 | |||
16th Annual Paragraph IV Disputes Conference | 09 November 2021 | |||
NERA Insights Webinar | Pay What? Arbitrating Disputes in Pharmaceutical Contracts | 27 July 2021 | |||
Generics: Pay-For-Delay, Patent Settlements, Reverse Payment, Price-Fixing & Market A... | 24 June 2021 | |||
GCR Interactive: Pharmaceuticals | 11 March 2021 | |||
NERA Insights Webinar Series: Intellectual Property | 19 November 2020 | |||
Title | Date | Type | ||
---|---|---|---|---|
NERA Economic Consulting Announces Senior-Level Promotions | 28 July 2022 | Press Release | ||
NERA Economic Consulting Announces Senior-Level Promotions | 23 February 2021 | Press Release | ||
Global Transfer Pricing Expert Joins NERA Economic Consulting | 10 September 2020 | Press Release | ||
NERA Economic Consulting Announces Senior-Level Promotions | 19 March 2019 | Press Release | ||
|